Athersys (NASDAQ:ATHX) Earns Hold Rating from Analysts at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX) in a report released on Saturday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.

Athersys Price Performance

The stock has a market capitalization of $833,000.00, a price-to-earnings ratio of -0.01 and a beta of -0.90. Athersys has a twelve month low of $0.01 and a twelve month high of $1.99.

About Athersys

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.